Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study.
Jourdain A, Auperin A, Minard-Colin V, Aladjidi N, Zsiros J, Coze C, Gandemer V, Bertrand Y, Leverger G, Bergeron C, Michon J, Patte C; SFCE LNH Committee. Jourdain A, et al. Among authors: patte c. Haematologica. 2015 Jun;100(6):810-7. doi: 10.3324/haematol.2014.121434. Epub 2015 Feb 27. Haematologica. 2015. PMID: 25724577 Free PMC article.
Excellent outcome of children/adolescents with primary mediastinal large B-cell lymphoma treated with a FAB/ LMB-based chemotherapy regimen with rituximab.
Dourthe ME, Auperin A, Rigaud C, Barbati M, Bonneau J, Buchbinder N, Couec ML, Dartigues P, Ducassou S, Garnier N, Haouy S, Jonca B, Jourdain A, Leruste A, Molina T, Montravers F, Pasquet M, Phulpin A, Poirée M, Simonin M, Spiegel A, Verschuur A, Leblanc T, Landman-Parker J, Patte C, Minard-Colin V. Dourthe ME, et al. Among authors: patte c. Haematologica. 2024 Nov 1;109(11):3790-3794. doi: 10.3324/haematol.2024.285403. Haematologica. 2024. PMID: 38988265 Free PMC article. No abstract available.
Erratum à l'article « Un programme d'éducation thérapeutique centré sur la transition des patients, avec endocrinopathie chronique, entre les services d'endocrinologie pédiatrique et adulte » [Presse Med. 45 (5) (2016) e119-e129].
Malivoir S, Courtillot C, Bachelot A, Chakhtoura Z, Téjédor I, Touraine P; Les référents pédiatres. Malivoir S, et al. Presse Med. 2016 Jul-Aug;45(7-8P1):718. doi: 10.1016/j.lpm.2016.06.012. Epub 2016 Jul 27. Presse Med. 2016. PMID: 27476021 French. No abstract available.
Neuropilin 2 and soluble neuropilin 2 in neuroendocrine neoplasms.
Gerard L, Patte C, Chardon L, Hervieu V, Payen L, Allio M, Marx C, Clermidy H, Durand A, Mehlen P, Bollard J, Poncet G, Roche C, Gibert B, Walter T. Gerard L, et al. Among authors: patte c. Endocr Relat Cancer. 2024 May 10;31(6):e240052. doi: 10.1530/ERC-24-0052. Print 2024 Jun 1. Endocr Relat Cancer. 2024. PMID: 38642579
The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group.
Mallon B, Kaboré R, Couitchere L, Akonde FB, Narison MLR, Budiongo A, Dackono TA, Pondy A, Diedhiou F, Patte C, Steliarova-Foucher E, Clavel J. Mallon B, et al. Among authors: patte c. Pediatr Blood Cancer. 2023 Dec;70(12):e30664. doi: 10.1002/pbc.30664. Epub 2023 Sep 21. Pediatr Blood Cancer. 2023. PMID: 37732944
Predictive factors of long-term follow-up attendance in very long-term childhood cancer survivors.
Dumas A, Milcent K, Bougas N, Bejarano-Quisoboni D, El Fayech C, Charreire H, Oberlin O, Patte C, Allard J, Thebault E, Boumaraf A, Belhout A, Giao VB, Souchard V, Jackson A, Allodji R, Valteau-Couanet D, Dufour C, Vassal G, Haddy N, De Vathaire F, Fresneau B. Dumas A, et al. Among authors: patte c. Cancer. 2023 Nov 1;129(21):3476-3489. doi: 10.1002/cncr.34944. Epub 2023 Jul 11. Cancer. 2023. PMID: 37432135 Free article.
Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial.
Alexander S, Aupérin A, Bomken S, Csóka M, Kazanowska B, Chiang AK, Andres M, Uyttebroeck A, Burke GAA, Zsiros J, Pillon M, Bollard CM, Mussolin L, Verdu-Amoros J, Neven B, Barkauskas DA, Wheatley K, Patte C, Gross TG, Minard-Colin V; Children's Oncology Group; European Intergroup for Childhood Non-Hodgkin's Lymphoma. Alexander S, et al. Among authors: patte c. Lancet Haematol. 2023 Jun;10(6):e445-e457. doi: 10.1016/S2352-3026(23)00062-5. Epub 2023 Apr 21. Lancet Haematol. 2023. PMID: 37094596 Free PMC article. Clinical Trial.
Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin's lymphoma.
Lueza B, Aupérin A, Rigaud C, Gross TG, Pillon M, Delgado RF, Uyttebroeck A, Amos Burke GA, Zsíros J, Csóka M, Simonin M, Patte C, Minard-Colin V, Bonastre J. Lueza B, et al. Among authors: patte c. Eur J Health Econ. 2024 Mar;25(2):307-317. doi: 10.1007/s10198-023-01581-y. Epub 2023 Apr 14. Eur J Health Econ. 2024. PMID: 37058173 Free PMC article.
236 results